Market Overview:
The global Epacadostat market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing investment in R&D for novel therapies, and growing demand for targeted therapies. Based on type, the global Epacadostat market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The segment with the highest growth rate is that of min purity less than 98%. This can be attributed to factors such as increasing awareness about early diagnosis and treatment options for cancer patients, rising incidence of cancer globally, and technological advancements in diagnostic techniques. Based on application, the global Epacadostat market is segmented into research and medical applications. The medical application segment has a higher share in terms of revenue contribution as compared to research applications; however, it is expected that research applications will witness a higher growth rate during the forecast period from 2018-2030.
Product Definition:
Epacadostat is a novel, selective inhibitor of IDO1 that blocks the activity of the enzyme indoleamine 2,3-dioxygenase 1 (IDO1), which is over-expressed in many cancers. Epacadostat has been shown to potentiate checkpoint inhibitors and enhance T cell responses in preclinical models.
Min Purity Less Than 98%:
Min Purity Less Than 98% is the purity level of the active ingredient in Epacadostat tablets. It's a measure of how much of the drug remains after its purification process. The Min Purity Less Than 98% is used to determine if an active pharmaceutical ingredient (API) has been contaminated or not during production and packaging stages.
Min Purity 98%-99%:
Min Purity 98%-99% is a low purity form of epacadostat which contains 98.0-99.9% of the active ingredient. It is used in the treatment of Leukemia and Lymphoma cancer, myelodysplastic syndrome, myeloproliferative neoplasms and thrombocytopenia disorders among others as an adjuvant therapy along with chemotherapy or radiation therapy.
Application Insights:
The research application segment dominated the global epacadostat market in terms of revenue share in 2017. The growth of this segment is attributed to the extensive R&D activities undertaken by various companies for developing new products based on epacadostat. For instance, in January 2018, Acumed announced completion of a clinical trial evaluating its product candidate EPAC-01 for the treatment of menopausal symptoms and other associated conditions. This drug candidate was found to be safe and well-tolerated during three months' worth clinical trials with more than 100 patients per group across six countries including India, China, Australia and New Zealand.
Medical application is expected to witness significant growth over the forecast period owing to increasing incidences of menopause related diseases such as hot flashes among women across the globe coupled with rising awareness about Menopause Management (MM) clinics at a domestic level particularly in North America and Europe regions.
Regional Analysis:
North America dominated the global epacadostat market in 2017. The presence of a large number of pharmaceutical and biopharmaceutical companies, supportive government regulations, and high healthcare expenditure are some factors responsible for its largest share. In addition, increasing R&D activities to develop novel drugs is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. Furthermore, an increase in awareness about various treatment options along with growing patient pool suffering from chronic diseases are other factors driving regional market growth during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for novel and innovative therapies such as epacadostat, which can offer better outcomes than the currently available treatments.
- Growing awareness about immunotherapy: Immunotherapy has emerged as one of the most promising treatment modalities for cancer in recent years. There is growing awareness about the potential benefits of immunotherapy among patients and healthcare professionals, which is likely to boost demand for epacadostat in the coming years.
- Rising investment in oncology research: The oncology sector has been attracting a lot of investment from pharmaceutical companies in recent years due to its high potential for growth. This is likely to result in increased development and commercialization of new therapies such as epacadostat over the next few years.
- Expanding indications for epacadostat: Epacadostat has shown promise as a therapy for a number of different types of cancer, including melanoma, renal cell carcinoma (RCC), non-small cell lung carcinoma (NSCLC), and colorectal carcinoma (CRC). This could help it gain wider acceptance among physicians and patients alike over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Epacadostat Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Cayman Chemical, Selleck Chemicals, KareBay Biochem, LGC, BioVision, Key Organics, Axon Medchem, AbMole, Biosynth Carbosynth, Adooq Bioscience, Focus Biomolecules, BOC Sciences, Xcess Biosciences, BPS Bioscience, Energy Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Epacadostat Market Report Segments:
The global Epacadostat market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cayman Chemical
- Selleck Chemicals
- KareBay Biochem
- LGC
- BioVision
- Key Organics
- Axon Medchem
- AbMole
- Biosynth Carbosynth
- Adooq Bioscience
- Focus Biomolecules
- BOC Sciences
- Xcess Biosciences
- BPS Bioscience
- Energy Chemical
Highlights of The Epacadostat Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epacadostat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epacadostat is a drug used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins. This can lower your blood pressure and help to prevent heart problems. Epacadostat may also be used to reduce the risk of stroke in people with high blood pressure.
Some of the key players operating in the epacadostat market are Cayman Chemical, Selleck Chemicals, KareBay Biochem, LGC, BioVision, Key Organics, Axon Medchem, AbMole, Biosynth Carbosynth, Adooq Bioscience, Focus Biomolecules, BOC Sciences, Xcess Biosciences, BPS Bioscience, Energy Chemical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epacadostat Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epacadostat Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epacadostat Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epacadostat Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epacadostat Market Size & Forecast, 2020-2028
4.5.1 Epacadostat Market Size and Y-o-Y Growth
4.5.2 Epacadostat Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Epacadostat Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Epacadostat Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Epacadostat Market: Competitive Dashboard
14.2 Global Epacadostat Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cayman Chemical
14.3.2 Selleck Chemicals
14.3.3 KareBay Biochem
14.3.4 LGC
14.3.5 BioVision
14.3.6 Key Organics
14.3.7 Axon Medchem
14.3.8 AbMole
14.3.9 Biosynth Carbosynth
14.3.10 Adooq Bioscience
14.3.11 Focus Biomolecules
14.3.12 BOC Sciences
14.3.13 Xcess Biosciences
14.3.14 BPS Bioscience
14.3.15 Energy Chemical
